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dEUROTRANSMITTER RECEPTORS IN THE LIFE
ND DEATH OF OLIGODENDROCYTES
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bstract—Oligodendrocytes are crucial to the function of the
ammalian brain: they increase the action potential conduction
peed for a given axon diameter and thus facilitate the rapid
ow of information between different brain areas. The prolifer-
tion and differentiation of developing oligodendrocytes, and
heir myelination of axons, are partly controlled by neurotrans-
itters. In addition, in models of conditions like stroke, periven-
ricular leukomalacia leading to cerebral palsy, spinal cord in-
ury and multiple sclerosis, oligodendrocytes are damaged by
lutamate and, contrary to dogma, it has recently been discov-
red that this damage is mediated in part by N-methyl-D-aspar-
ate receptors. Mutations in oligodendrocyte neurotransmitter
eceptors or their interacting proteins may cause defects in
NS function. Here we review the roles of neurotransmitter
eceptors in the normal function, and malfunction in patholog-
cal conditions, of oligodendrocytes.
© 2006 IBRO. Published by Elsevier Ltd.
ey words: glutamate, NMDA, development, ischemia, cere-
ral palsy, multiple sclerosis.
or normal brain function, it is essential that signals pass
apidly between neurons. Oligodendrocytes play an impor-
ant role in assuring fast neuronal signaling in the CNS. By
overing neuronal axons with myelin, which decreases
he effective axonal membrane capacitance, they reduce the
harge needed to depolarize the axon and hence allow the
ction potential to travel much faster, by saltatory conduction
rom one node of Ranvier to the next, at speeds of up to
30 km/h (120 m/s) instead of 3.6 km/h (1 m/s) for a
ypical (smaller) unmyelinated axon.
During development oligodendrocytes are generated
rom precursor cells with a morphology that is bipolar
when migrating) or stellate (after migration). These initially
ifferentiate into immature cells that put out processes
eeking axons to myelinate, and eventually form mature
ells with parallel processes myelinating up to 30 different
xons. The production of myelinated axons requires a
recise matching of the number of oligodendrocytes gen-
rated to the length of axons to be myelinated. This may be
egulated in part by neurotransmitter receptors activated
y substances released by active axons. Such interactions
ay also be important for maintaining the myelination of
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Open access under CC BY licenseature axons. Thus, neurotransmitter receptors play an
mportant role in the normal life of oligodendrocytes.
Furthermore, if oligodendrocytes become damaged
nd the myelin sheath is destroyed, the action potential is
educed in velocity or ceases altogether, leading to phys-
cal or mental disability. This occurs in cerebral palsy
which affects about one in 500 live births), spinal cord
njury (which happens to one in 1200 people), stroke (suf-
ered by one in 450 people each year) and multiple scle-
osis (present in one in 700 people). Recent work has
hown that neurotransmitter receptors play a key role in
amaging oligodendrocytes in pathological conditions. Un-
erstanding how this damage happens would provide
ome prospect of either preventing or reversing it.
In this review we will describe the neurotransmitter
eceptors present on oligodendrocytes, discuss how they
ay control oligodendrocyte development, examine how
ctivation of these receptors contributes to oligodendro-
yte damage in pathological conditions, and assess what
s known about how mutations in neurotransmitter recep-
ors or their interacting proteins may alter oligodendrocyte
unction.
NEUROTRANSMITTER RECEPTOR
EXPRESSION IN OLIGODENDROCYTES
MPA/kainate receptors
lutamate evokes a membrane current in oligodendro-
ytes which has been reported to be generated entirely by
MPA or kainate receptors, both in culture (Barres et al.,
990; Patneau et al., 1994; Borges et al., 1994; Borges
nd Kettenmann, 1995; Gallo et al., 1996; Yuan et al.,
998) and in brain slices (Berger et al., 1992b). Consistent
ith the presence of functional AMPA and kainate recep-
ors, oligodendrocytes express mRNA for the AMPA re-
eptor subunits GluR2, 3 and 4, but not for GluR1 (Pat-
eau et al., 1994; Itoh et al., 2002; Yoshioka et al., 1996;
arcia-Barcina and Matute, 1998; Matute et al., 1997;
ensen and Chiu, 1993), and for the kainate receptor
ubunits GluR6 and 7 and KA-1 and 2, but not for GluR5
Jensen and Chiu, 1993; Patneau et al., 1994; Yoshioka et
l., 1996; Garcia-Barcina and Matute, 1996; Matute et al.,
997). Interestingly, when detecting AMPA/kainate sub-
nits at the protein level with immunohistochemistry, no
luR2 subunit was found in the oligodendrocytes, but
luR3 and GluR4 were expressed (Li and Stys, 2000), and
mmunoprecipitation experiments reported that GluR2
oes not assemble with the other subunits (Puchalski et
l., 1994). These data suggest that the AMPA receptors
resent may lack GluR2 and therefore be Ca2-perme-
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R. Káradóttir and D. Attwell / Neuroscience 145 (2007) 1426–1438 1427ble, which has relevance for the damaging actions of
lutamate on oligodendrocytes in pathology, as discussed
elow.
Changes in glutamate receptor expression with devel-
pment may be relevant for understanding the susceptibil-
ty of oligodendrocyte precursors and immature cells to
noxia or ischemia, as discussed below, but there is pro-
ound disagreement in the literature over how the gluta-
ate-evoked current changes with oligodendrocyte matu-
ation. On the one hand, it has been claimed that, in
ulture, the glutamate response is larger in precursor or
mmature cells than in mature oligodendrocytes (Borges et
l., 1994; Itoh et al., 2002; Deng et al., 2003; Rosenberg et
l., 2003). Alternatively, in brain slices, the glutamate-
voked current has been suggested not to differ signifi-
antly between precursor oligodendrocytes and mature
ligodendrocytes (Berger et al., 1992b). Finally, it has
een reported that, in culture and in slices, the glutamate
esponse in mature cells is larger than in precursors (Pat-
eau et al., 1994; Káradóttir et al., 2005), although the
ncrease of the glutamate-evoked current could just reflect
he increase of the cell’s size with development, with no
hange of receptor density.
-methyl-D-aspartate (NMDA) receptors
euronal NMDA receptors are important for learning and
emory, and for causing neuronal death in pathological
onditions, but until recently were assumed to be absent
rom glia: for over 10 years it has been the dogma that
ligodendrocytes do not express NMDA receptors. No
essage was detected for NMDA receptor subunits in the
ptic nerve (Matute et al., 1997), and NMDA was reported
o generate no current in oligodendrocytes, either in culture
Barres et al., 1990; Patneau et al., 1994; Pende et al.,
994) or in brain slices (Berger et al., 1992b). However,
here were some indications that NMDA receptors might
e present. Yoshioka et al. (1996) reported that an oligo-
endrocyte precursor cell line expressed mRNA for NR1
nd NR2D, and Wang et al. (1996) showed that, in culture,
-2A cells (precursor cells that can become either oligo-
endrocytes or type 2 astrocytes) exhibited NMDA-evoked
urrents that were magnesium-blocked and reduced with
n NMDA antagonist. The latter finding was supported by
demonstration that mature spinal cord gray matter oligo-
endrocytes showed NMDA-evoked currents, but contra-
icted by the fact that no NMDA response was seen in the
recursor oligodendrocytes which one would expect to
ehave like the O-2A cells studied in culture (Žiak et al.,
998); essentially no NMDA responses were detected in
hite matter oligodendrocytes in that study.
Recently we have shown (Káradóttir et al., 2005) that
hite matter oligodendrocytes express functional NMDA
eceptors, in situ in slices of cerebellum and corpus callo-
um, at all developmental stages, i.e. in cells expressing
arkers for oligodendrocyte precursors (NG2), immature
ells (O4) and mature myelinating oligodendrocytes (my-
lin basic protein). These receptors are unusual in showing
ery weak block by extracellular Mg2: 2 mM Mg2 re-
uced the current only three- to fivefold relative to that ceen in the absence of Mg2, whereas for neuronal recep-
ors the reduction is normally 20–70-fold. Thus, oligoden-
rocyte NMDA receptors generate a significant current
ven at the cell’s resting potential of around 60 mV. The
eak Mg2-block, together with antibody labeling for par-
icular NMDA receptor subunits, suggested that the recep-
ors might be composed of NR1, NR2C and NR3 subunits
Káradóttir et al., 2005). NR2C and NR3 subunits tend to
onfer a weak Mg2-block on NMDA receptors (Kuner and
choepfer, 1996; Sasaki et al., 2002), although this sug-
ested subunit combination has not been studied in a
eterologous expression system yet. Similar immunocyto-
hemistry showed that NMDA receptor subunits are also
resent in optic nerve oligodendrocytes (Salter and Fern,
005; Micu et al., 2006), suggesting that NMDA receptor
xpression may be a general property of oligodendrocytes
hroughout the brain. Although NMDA-evoked currents
ere demonstrated by Káradóttir et al. (2005) only over the
ge range investigated, from P7–P14, they demonstrated
hat adult rat oligodendrocytes generating compact myelin
lso express NMDA receptor subunits (see below).
he subcellular localization of glutamate receptors in
ligodendrocytes
mmunocytochemical localization of NMDA receptors in
ature oligodendrocytes, both in cerebellar and corpus
allosum slices and in optic nerve, shows a high level of
xpression in the cell processes which invest axons with
yelin (Káradóttir et al., 2005; Salter and Fern, 2005; Micu
t al., 2006) whereas, by contrast, AMPA/kainate recep-
ors tended to be expressed mainly in the cell soma. At the
lectron microscopic level, NR1 subunits were found to be
resent throughout the myelin, even in the compact myelin
round adult axons (Káradóttir et al., 2005). The preferen-
ial location of NMDA receptors in myelinating processes
Fig. 1) suggests a possible role in controlling axon–oligo-
endrocyte interactions during myelination, and is consis-
ent with activation of these receptors damaging the my-
linating processes specifically in pathological conditions
s discussed below. It is hard to see how receptors deep
ithin the myelin will ever be exposed to glutamate, and
hey may be left there as a consequence of development.
owever, receptors in the inner myelin lamina should be
ble to respond to glutamate released from the axon being
yelinated, and receptors in the outer lamina may be used
or sensing glutamate release from cells surrounding the
xon/myelin unit.
hy were oligodendrocyte NMDA receptors
verlooked for so long?
everal factors probably account for the long-held dogma
hat oligodendrocytes do not express NMDA receptors.
irst, the early papers reporting no NMDA-evoked currents
n oligodendrocytes (Barres et al., 1990; Patneau et al.,
994; Pende et al., 1994) were on cultured cells, main-
ained in conditions which may down-regulate NMDA re-
eptor expression. Second, the brain slice experiments of
erger et al. (1992b) were on corpus callosal oligodendro-
ytes, the NMDA receptors of which show more desensi-
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R. Káradóttir and D. Attwell / Neuroscience 145 (2007) 1426–14381428ization than for cerebellar oligodendrocytes (Bakiri et al.,
006) which may have led to an NMDA response being
verlooked if NMDA was only applied after glutamate had
lready activated (and desensitized) the NMDA receptors.
hird, the preferential location of NMDA receptors in cell
rocesses, rather than in the cell somata where more
MPA/kainate receptors are located, may mean that in
tudies of glutamate damaging oligodendrocytes (which
sually involve using an agent like propidium to label nu-
lear DNA when the cell membrane ruptures) a damaging
ffect of AMPA/kainate receptors may be more easily de-
ected (see discussion below). Finally, in many studies
tudying the role of AMPA/kainate receptors in damaging
ligodendrocytes in simulated pathology, because of the
ogma that oligodendrocytes do not express NMDA recep-
ors, and a desire to avoid NMDA receptor-mediated ef-
ects occurring in the gray matter, the “control” condition
ften included an NMDA receptor blocker in the solution.
he outcome in this “control” condition would then be
ompared with what occurred when an AMPA/kainate
locker was superimposed on the NMDA blocker. This
rocedure automatically excludes detection of any influ-
nce of NMDA receptors.
etabotropic glutamate receptors (mGluRs)
GluRs are expressed in oligodendrocytes (Deng et al.,
004), but the mGluR agonist ACPD evokes neither a
urrent nor a rise in intracellular calcium level in oligoden-
ig. 1. Spatial segregation of NMDA and AMPA/kainate receptors in m
ocated on the soma, while NMDA receptors (yellow) are preferentially l
utaway of myelin shows that NMDA receptors are found in the outer m
yelin (m). This schematic diagram of the myelin ignores the fact t
utermost turns of the myelin.rocytes (Berger et al., 1992b; Borges et al., 1994; Pende dt al., 1994; Káradóttir et al., 2005), but see Holtzclaw et al.
1995) for an mGluR-mediated [Ca2]i rise in cultured
ligodendrocyte precursors.
ources of glutamate to activate oligodendrocyte
lutamate receptors
ligodendrocyte precursors in both the gray and the white
atter receive glutamatergic synaptic input evoked by ac-
ion potentials in axons: synaptic events in oligodendrocyte
recursors are blocked by TTX and by the Ca2 channel
locker cadmium (Bergles et al., 2000; Káradóttir et al.,
005). Glutamate may also be released onto mature oli-
odendrocytes. Both frog sciatic nerve (Wheeler et al.,
966) and frog optic nerve axons (Weinreich and Hammer-
chlag, 1975) release preloaded radioactive glutamate in
esponse to repetitive electrical stimulation. Moreover, ax-
nal stimulation, or application of veratridine which gener-
tes action potentials, causes the calcium concentration to
ise in mammalian optic nerve glial cells, and this is
locked by kynurenic acid (a non-specific glutamate recep-
or antagonist) but also by blocking glutamate transporters
ith dihydrokainate (Kriegler and Chiu, 1993; Chiu and
riegler, 1994). The effect of the transporter blocker can
e explained by the fact that axonal action potentials will
ncrease the intracellular sodium concentration and the
xtracellular potassium concentration. This could make
xonal glutamate transporters reverse their operation and
elease glutamate, since uptake by glutamate transporters
g oligodendrocytes. AMPA/kainate receptors (blue) are preferentially
n the myelinating processes, although this segregation is not absolute.
p (o), the inner wrap (i) nearest the axon, and also deep in the compact
ligodendrocyte cytoplasm is, in reality, thicker in the innermost andyelinatin
ocated o
yelin wraepends on there being a low intracellular sodium concen-
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R. Káradóttir and D. Attwell / Neuroscience 145 (2007) 1426–1438 1429ration and a low extracellular potassium concentration:
hen these concentrations rise, the transporters tend to
elease glutamate (Szatkowski et al., 1990). In ischemic
onditions, as discussed below, glutamate is released both
rom axons and from oligodendrocytes by reversal of glu-
amate transporters (Li et al., 1999; Fern and Möller,
000). In subsequent sections we will describe the likely
unctional consequences of glutamate release activating
ts receptors on oligodendrocytes.
ABA and other neurotransmitter receptor
xpression
ABA evokes a GABAA receptor-mediated current in oli-
odendrocytes throughout their development (Pastor et
l., 1995; Matute et al., 1997; Williamson et al., 1998).
ABA depolarizes both mature and precursor cells (Butt
nd Tutton, 1992; Lin and Bergles, 2004) and raises the
ntracellular calcium concentration (Belachew et al., 1998;
ernstein et al., 1996; Schmidt et al., 2000; Kirchhoff and
ettenmann, 1992), suggesting that the chloride reversal
otential, ECl, is above the resting potential. The elevated
ntracellular [Cl]i needed to generate this depolarized
alue of ECl is presumably produced by the expression of
KCC1 transporters which carry Cl into the cell (Plotkin
t al., 1997). Examining the message for GABAA receptor
ubunits in precursor oligodendrocytes showed that they
xpress mRNA for 2, 3, 4, 5, 2, 3 and to a lesser
xtent 1, subunits, while  subunits were not detected and
subunits were not tested for (Williamson et al., 1998), so
he exact subunit composition of the receptors remains to
e determined. Oligodendrocyte precursors in both gray
nd white matter receive GABAergic synaptic input from
xons (Lin and Bergles, 2004; Káradóttir and Attwell,
006), and it is conceivable that mature cells are exposed
o GABA released by reversed uptake in inhibitory axons,
s discussed above for glutamate.
Glycine evokes an inward current in oligodendrocyte pre-
ursor cells, mediated by strychnine-sensitive receptors gat-
ng a Cl conductance and by activation of Na-dependent
lycine uptake, which depolarizes the cells and increases the
ntracellular calcium level (Pastor et al., 1995; Belachew et
l., 1998, 2000). Serotonin and ACh are reported to generate
n inward current in oligodendrocytes in culture but not in
lices (Belachew et al., 1998; Káradóttir et al., 2005). Hista-
ine, norepinephrine, serotonin, angiotensin II, bradykinin,
ubstance P, acetylcholine and ATP all raise [Ca2]i in oligo-
endrocyte precursor cells (Bernstein et al., 1996; Belachew
t al., 1998; Ragheb et al., 2001). Adenosine also increases
he intracellular calcium concentration, oligodendrocytes ex-
ress mRNA for the A1, A2a, A2b and A3 subunits of aden-
sine receptors (Stevens et al., 2002), and the A1 receptor
ubunit has been detected at the protein level (Othman et al.,
003). Finally, oligodendrocytes at all maturational stages
xpress mRNA for D3 dopamine receptors, so dopamine
resumably lowers the cyclic AMP level in these cells (Bon-
arzone et al., 1998).
Below we will consider the functional significance of
hese receptors being present. tTHE ROLE OF NEUROTRANSMITTER
RECEPTORS IN THE DEVELOPMENT OF
OLIGODENDROCYTES
xonal activity affects oligodendrocyte development
he number of mature myelinating oligodendrocytes pro-
uced during CNS development needs to be matched to
he number and length of the axons requiring myelination.
n addition, oligodendrocytes migrate along axons to reach
heir targets (Kakita et al., 2003; Small et al., 1987; Baulac
t al., 1987; Kiernan and ffrench-Constant, 1993). One
ay to regulate these processes would be for factors to be
eleased locally from axons to control the proliferation,
ifferentiation and migration of oligodendrocytes. Indeed,
he electrical activity of axons promotes oligodendrocyte
roliferation and survival (Barres and Raff, 1993; Barres
t al., 1993). If axonal electrical activity is inhibited with
TX, it disrupts oligodendrocyte development and myeli-
ation without affecting axons (Friedman and Shatz, 1990;
emerens et al., 1996) [but see, however, Colello et al.
1995) who claimed that myelination was unaffected by
lectrical activity in axons, and suggested that the precur-
ors already present at the age (P0) when they blocked
lectrical activity were sufficient to myelinate the axons
resent]. In addition, an increase in axonal firing promotes
he differentiation of oligodendrocytes and increases my-
lination (Demerens et al., 1996; Stevens et al., 2002).
Although PDGF may be one substance released, as a
esult of activity in axons, that influences oligodendrocyte
evelopment (Barres and Raff, 1993), there is increasing
vidence for a role of smaller transmitter molecules, par-
icularly glutamate, adenosine and ATP. As noted above,
here is exocytotic release of glutamate onto oligodendro-
yte precursors (Bergles et al., 2000; Káradóttir et al.,
005), and release by reversal of glutamate transporters
ven at later developmental stages (Li et al., 1999; Fern
nd Möller, 2000). Interestingly, in neonatal optic nerve,
xonal stimulation increases the extracellular potassium
evel (from 5 to 20 mM for 20 Hz stimulation) more than in
ature optic nerve (from 5 to 11 mM for 400 Hz stimula-
ion), and the increase in potassium concentration pro-
uced by a single stimulus was seven times higher in
eonatal than in mature optic nerve (Connors et al., 1982).
his larger increase of [K]o, which will promote a stronger
eversal of glutamate transporters, occurs within the first
ostnatal week, before myelination has begun (Foster et
l., 1982), suggesting that the axonal physiology (and
erhaps lack of K buffering by astrocytes) facilitates more
lutamate release from active axons by reversed uptake at
he time in development when oligodendrocytes start to
ecome mature.
ffects of glutamate on oligodendrocyte proliferation
nd differentiation
everal studies suggest a role for glutamate receptors in
ontrolling oligodendrocyte development (Fig. 2), although
heir results are not all mutually consistent. Firstly, activa-
ion of NMDA receptors on cultured oligodendrocyte pre-
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heir NMDA receptors decreased migration by 90%, while
nhibiting AMPA receptors reduced migration by 40%
Wang et al., 1996). Gudz et al. (2006) found that the
romoting effect of AMPA receptor activation on migration
as associated with the formation of an V integrin/prote-
lipid protein/AMPA receptor complex, possibly mediated
y a [Ca]i rise produced by the receptors, but (contradict-
ng the work of Wang et al., 1996) they found no effect of
ig. 2. Control of oligodendrocyte development by neurotransmitters.
igrate and proliferate, through immature oligodendrocytes, which se
rocytes that form myelin sheaths. Blue arrows show positive effects o
eleased (green) from active axons. Glutamate is released by exocytos
he mechanism of release of ATP is uncertain. ATP is converted to
eukemia inhibitory factor (LIF). GABA is also released by exocytosis o
nknown.MDA receptor activation on migration. Secondly, gluta- iate acts through AMPA or kainate (but not NMDA) re-
eptors on oligodendrocyte precursors to decrease prolif-
ration, and also inhibits the proliferation and lineage pro-
ression induced by PDGF and bFGF (Gallo et al., 1996;
uan et al., 1998). Even though glutamate blocked prolif-
ration, it did not seem to promote migration (contradicting
he work of Wang et al. (1996) and Gudz et al. (2006)).
nterestingly, there is an interaction between glutamate
nd the growth factors that control proliferation. bFGF
ows show the progression of oligodendrocytes from precursors, which
ocesses seeking axons to myelinate, to mature myelinating oligoden-
nsmitters; red arrows show inhibitory effects. Glutamate and ATP are
ligodendrocyte precursors, and by reversed uptake onto mature cells.
e by extracellular ATPases. ATP also induces astrocytes to release
rsors; the origins and release mechanisms for ACh and dopamine areBlack arr
nd out pr
f neurotra
is onto o
adenosin
nto precuncreases the expression of kainate (GluR7, KA1 and KA2)
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R. Káradóttir and D. Attwell / Neuroscience 145 (2007) 1426–1438 1431nd AMPA (GluR4) receptor subunits, while PDGF in-
reases GluR1 subunit expression, and both growth fac-
ors together increase even further the expression of
luR1 and augment the AMPA-evoked current in oligo-
endrocyte precursors (Gallo et al., 1994; Chew et al.,
997).
Glutamate-evoked inhibition of proliferation in oligo-
endrocyte precursors may serve to decrease the number
f oligodendrocytes produced once the migrating precur-
ors arrive near axons releasing glutamate. It is perhaps
urprising that the growth factors that promote proliferation
lso increase the expression of glutamate receptors which
ecrease proliferation. However, to understand the possi-
le roles of PDGF and glutamate it is necessary to know
ow far these messengers spread; conceivably PDGF
preads farther than glutamate (which is efficiently taken
p) and acts on oligodendrocytes at some distance from
ctive axons, increasing glutamate receptor expression so
hat proliferation is only turned off when the cells arrive
ear the axons and can sense the glutamate they are
eleasing.
The mechanism by which glutamate blocks oligoden-
rocyte proliferation, both in culture and in brain slices, is
pparently by raising the intracellular sodium concentra-
ion, and thus inhibiting delayed rectifier K channels
hich are expressed in oligodendrocyte precursors but not
n mature cells (Berger et al., 1991; Borges et al., 1994;
orges and Kettenmann, 1995; Gallo et al., 1996; Knutson
t al., 1997; Yuan et al., 1998). The resulting inhibition of
utward K flux leads to a depolarization of the cells.
onsistent with a role for K channels in regulating prolif-
ration, increased expression of the voltage-gated channel
ubunits Kv1.3 and Kv1.4 increases oligodendrocyte pro-
iferation (Vautier et al., 2004), and PDGF (which also
ncreases proliferation: Barres and Raff, 1993) increases
xpression of outward rectifying potassium channels (Chit-
ajallu et al., 2005). Moreover, the glutamate-evoked inhi-
ition of proliferation is mimicked by tetraethylammonium
ons, which block K channels, and is unaffected by cal-
ium removal (Gallo et al., 1996; Knutson et al., 1997;
uan et al., 1998) which rules out the possibility that the
nhibition of proliferation is produced by oligodendrocyte
epolarization leading to activation of voltage-gated Ca2
hannels and a Ca2 influx. The dependence of gluta-
ate’s actions on Na entry is demonstrated by the fact
hat when applying glutamate (or kainate) with N-methyl-
-glucamine replacing extracellular Na, the glutamate-
voked inhibition of K outward current does not occur
Knutson et al., 1997). In addition, if the intracellular Na
oncentration is increased with veratridine, a similar inhi-
ition of the outward potassium current and of oligoden-
rocyte proliferation is produced, even in the presence of
DGF and bFGF (Knutson et al., 1997; Yuan et al., 1998).
Apart from effects of glutamate mediated by K chan-
el closure, when glutamate activates its receptors it will
lso increase the intracellular calcium concentration which
ay activate various enzymes. Activation of non-NMDA
eceptors on oligodendrocyte precursor cells leads to an
ncrease in intracellular calcium concentration, that in- Auces an increase in gene expression since it increases
RNA levels for nuclear messengers like immediate early
enes (Pende et al., 1994; Holtzclaw et al., 1995). High
ntracellular [Ca2] could also activate protein kinase C,
hich inhibits differentiation and myelin basic protein ex-
ression (Baron et al., 1998).
Although the longstanding notion that oligodendro-
ytes do not express NMDA receptors led to a focus on
evelopmental effects mediated by non-NMDA receptors,
t is likely that the recent discovery of NMDA receptors in
hese cells will stimulate a reexamination of the possible
ole of NMDA receptor-mediated depolarization and
Ca2]i rise on oligodendrocyte development. In particular,
he location of NMDA receptors in oligodendrocyte myeli-
ating processes (see above) suggests a possible role for
hese receptors in controlling myelination.
ffects of ATP and adenosine on oligodendrocyte
evelopment
hereas glutamate has so far only been shown to regulate
he early development of oligodendrocytes, adenosine and
TP are modulators of late oligodendrocyte development
nd myelination (Fig. 2). ATP is released by electrical
timulation of dorsal root ganglion axons, while adenosine
ay also be released or may be generated by extracellular
TPases from released ATP. Adenosine activates recep-
ors on oligodendrocyte precursor cells, raising [Ca2]i and
ecreasing proliferation of the cells, and stimulating migra-
ion, differentiation and thus myelin formation (Stevens et
l., 2002; Othman et al., 2003). ATP acts at a later stage of
evelopment, when adenosine no longer promotes myeli-
ation. It acts indirectly, inducing astrocytes to release the
ytokine LIF which enhances myelination by maturing oli-
odendrocytes (Ishibashi et al., 2006). By contrast, in the
eripheral nervous system ATP released from axons in-
ibits myelination by Schwann cells (Stevens and Fields,
000).
ffects of other neurotransmitters on
ligodendrocyte development
here is only fragmentary evidence for a role of other
eurotransmitters in modulating oligodendrocyte develop-
ent, as follows. When GABA activates GABAA receptors
n oligodendrocyte precursor cells (Lin and Bergles, 2004),
t may also inhibit outward rectifying potassium channels
Pastor et al., 1995), which could lead to depolarization
nd a reduction of proliferation as shown for glutamate
see above) and as also occurs for neurons (LoTurco et al.,
995). The acetylcholine muscarinic M3 receptor is ex-
ressed in oligodendrocyte precursors and when activated
t increases proliferation by activating the MAP kinase
ignaling pathway (Ragheb et al., 2001). Furthermore,
ctivation of dopaminergic D3 receptors, which are ex-
ressed in precursor and immature oligodendrocytes (but
ot in mature cells), decreases differentiation of the pre-
ursor cells to become mature cells and inhibits myelin
ormation (Bongarzone et al., 1998). Finally, since hista-
ine, norepinephrine, serotonin, angiotensin II, bradykinin,
TP and substance P have all been shown to increase the
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R. Káradóttir and D. Attwell / Neuroscience 145 (2007) 1426–14381432ntracellular calcium concentration in oligodendrocyte pre-
ursors (Bernstein et al., 1996), these transmitters could
lso influence the development of the oligodendrocytes if
hey are released onto the cells in vivo.
THE ROLE OF NEUROTRANSMITTER
RECEPTORS IN MATURE
OLIGODENDROCYTES
ature myelinating oligodendrocytes respond to neuro-
ransmitters, as documented above, but the role of this
ignaling is completely obscure. Conceivably constant sig-
aling from axons to the myelin surrounding them is es-
ential for myelination to be maintained, but this remains to
e tested.
THE ROLE OF NEUROTRANSMITTER
RECEPTORS IN OLIGODENDROCYTE
PATHOLOGY
lutamate release damages oligodendrocytes in
athological conditions
n pathological conditions neurotransmitters can be re-
eased excessively, damaging the cells they normally act
n. In the gray matter of the brain the death of neurons in
athological conditions is often caused by a rise of extra-
ellular glutamate concentration activating NMDA recep-
ors and causing an excessive rise of [Ca2]i. This occurs
n anoxia or ischemia (Olney, 1978; Choi et al., 1987; Choi,
ig. 3. Receptor distribution defines the spatial segregation of damag
y reversal of uptake carriers (orange) in conditions of energy depriva
he inner wrap (i) of the myelin, leading to ion flux into the myelin
MPA/kainate receptors (blue) on the soma (possibly leading to death of the so
yelin.988; Arundine and Tymianski, 2004), but also in more
hronic conditions such as Huntington’s or Alzheimer’s
isease (Hynd et al., 2004). Glutamate can also damage
hite matter oligodendrocytes, in both acute and chronic
iseases, including brain injury after pre- or perinatal in-
ection, asphyxia or premature birth (periventricular leu-
omalacia, leading to cerebral palsy and cognitive deficits
Volpe, 2001)), spinal cord injury (Stys, 2004), multiple
clerosis (Matute et al., 2001) and stroke (Dewar et al.,
003). In perinatal asphyxia and spinal cord injury gluta-
ate is released in the white matter by the reversal of
lutamate transporters in axons and oligodendrocytes
Fig. 3) as a result of ATP depletion (Li et al., 1999; Fern
nd Möller, 2000), i.e. a mechanism similar to that occur-
ing in gray matter ischemia (Rossi et al., 2000). In multiple
clerosis, the extracellular glutamate concentration may
ise as a result of release by cystine–glutamate exchange
n microglia/macrophages (Piani and Fontana, 1994), or
ecause of increased glutamate production by glutami-
ase and reduced degradation by glutamate dehydroge-
ase and glutamine synthetase (Werner et al., 2001).
lutamate-mediated damage to oligodendrocytes
ediated by AMPA/KA receptors
ntil recently, there was thought to be a major difference
etween the excitotoxic actions of glutamate on oligoden-
rocytes and on neurons because, as noted above, it was
hought that oligodendrocytes lacked NMDA receptors
Berger et al., 1992a; Patneau et al., 1994). Oligodendro-
d when glutamate (glu) is released from axons and oligodendrocytes
amate released from axons will activate NMDA receptors (yellow) on
lin damage. Glutamate released from oligodendrocytes will activatee expecte
tion. Glut
and myema) and also NMDA receptors on the inner and outer (o) wraps of the
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R. Káradóttir and D. Attwell / Neuroscience 145 (2007) 1426–1438 1433ytes were therefore thought to be damaged solely by
lutamate acting either on calcium-permeable AMPA/kai-
ate receptors (Dewar et al., 2003; Stys, 2004; Volpe,
001; Matute et al., 2001) or by reversing cystine–gluta-
ate exchange and depriving the cells of antioxidant pro-
ection (Oka et al., 1993).
Consistent with a role for AMPA/kainate receptors in
lutamate-mediated oligodendrocyte damage, blocking
hese receptors attenuates white matter injury in animal
odels of hypoxia/ischemia (Tekkök and Goldberg, 2001;
ern and Möller, 2000; Follett et al., 2000; Deng et al.,
003; McDonald et al., 1998), spinal cord injury (Wrathall
t al., 1997; Agrawal and Fehlings, 1997) and multiple
clerosis (Smith et al., 2000; Pitt et al., 2000). In addition,
hite matter damage in periventricular leukomalacia oc-
urs at a time in development when a large proportion of
ligodendrocytes are precursor and immature cells (Back
t al., 2002). In culture these have been reported to show
higher expression than mature cells of AMPA/kainate
eceptors and downstream [Ca2] signaling (Itoh et al.,
002; Deng et al., 2003; Rosenberg et al., 2003), although
here are reports disputing this as described above.
In addition to simple activation of AMPA/kainate re-
eptors damaging oligodendrocytes, there is also a glu-
amate–immune system interaction, between the effects
f activating kainate receptors and the effects of com-
lement attack by microglia/macrophages in multiple scle-
osis (or its animal model experimental autoimmune en-
ephalomyelitis). Concentrations of glutamate which alone
re not toxic, sensitize oligodendrocytes to subsequent
omplement attack (Alberdi et al., 2006), which inserts
embrane attack complexes into the oligodendrocyte, al-
owing a toxic Ca2 influx to occur.
he role of NMDA receptors in glutamate-mediated
amage to oligodendrocytes
espite the long-held consensus view that glutamate dam-
ges white matter oligodendrocytes and their precursors
y acting on AMPA/kainate receptors, there was some
vidence that NMDA receptors might also play a role.
MDA receptor blockers slow the loss of white matter
ction potentials (Tekkök and Goldberg, 2001) and reduce
hite matter damage in ischemia (Schäbitz et al., 2000)
nd in an animal model of multiple sclerosis (Wallström et
l., 1996).
In fact, both in oligodendrocyte precursors and in ma-
ure oligodendrocytes myelinating axons, NMDA receptors
re activated by glutamate released during simulated white
atter ischemia (Káradóttir et al., 2005). Activation of
hese receptors leads to a rise of [Ca2]i in the myelinating
rocesses of mature cells (Micu et al., 2006), to which
ctivation of AMPA/kainate receptors contributes only
odestly, whereas activation of AMPA/kainate receptors is
esponsible for essentially all of the [Ca2]i rise in the cell
ody. This differential route of calcium entry is consistent
ith the segregated distribution of the different receptor
lasses on the cell (Fig. 3). Activation of an ion influx
hrough the NMDA receptors on the myelinating processes
eads to these processes rupturing in young animals mSalter and Fern, 2005) and in adult animals to the com-
act myelin becoming seriously deformed (Micu et al.,
006). A likely factor contributing to this damage to the
yelinating processes is the small intracellular volume of
hese processes, which will result in a large fractional
oncentration change of [Na] and [Ca2]i in the cell,
esulting in water influx and swelling. The resulting disrup-
ion of the myelin sheath (Salter and Fern, 2005; Micu et
l., 2006) must slow or abolish action potential propaga-
ion, but at present it is unknown whether oligodendrocytes
an recover from this damage to their processes. In addi-
ion it is unclear whether damage to the processes medi-
ted by NMDA receptors will be detected by propidium
odide as commonly used to detect rupture of the plasma
embrane: conceivably when the processes become
amaged the rest of the cell seals off its membrane and the
oma can live on and perhaps regenerate new processes,
roviding the rise of glutamate around the soma does not
ctivate AMPA/kainate receptors sufficiently to kill the
oma.
ligodendrocyte NMDA receptors as a therapeutic
arget in white matter disease
o far a role for NMDA receptors in damaging oligoden-
rocytes has only been directly shown in simulated isch-
mic conditions. However, since the extracellular gluta-
ate concentration is thought to rise in the white matter not
nly in ischemia, but also in spinal cord injury and multiple
clerosis, it is likely that a similar damage induction pro-
ess occurs in these other conditions (just as activation of
ligodendrocyte AMPA/kainate receptors occurs not only
n ischemia but also in animal models of multiple sclerosis:
itt et al., 2000; Smith et al., 2000). This suggests that
ligodendrocyte NMDA receptors would be a useful ther-
peutic target in a range of white matter diseases.
The fact that these receptors have a subunit stoichi-
metry that differs from most neuronal NMDA receptors
see above) suggests the possibility of devising a drug that
locks these receptors specifically, avoiding the problems
f side effects on neuronal receptors that have prevented
seful therapeutic application of NMDA receptor blockers
n stroke (Lipton, 2006). Furthermore, the damage to the
hite matter which occurs in spinal cord injury (as a sec-
ndary consequence of damage to blood vessels) and in
ultiple sclerosis progresses slowly, which should give a
herapeutic time window in which NMDA blockers could be
iven. Interestingly memantine, one of the few NMDA an-
agonists licensed for use in humans, blocks the oligoden-
rocyte NMDA receptors (Bakiri et al., 2006), and so might
rovide a useful starting point for testing the therapeutic
ffects of NMDA blockers in white matter diseases.
he role of GABA and other neurotransmitters in
hite matter ischemia
ust as glutamate receptors play a role in damaging oligo-
endrocytes in pathological conditions, it is possible that
ther neurotransmitter receptors on these cells may exac-
rbate or reduce damage to oligodendrocytes in white
atter diseases.
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R. Káradóttir and D. Attwell / Neuroscience 145 (2007) 1426–14381434In both the gray and the white matter there is an
ncrease in the extracellular GABA concentration during
schemia (Shimada et al., 1993). In gray matter, GABA
elease is either thought to be beneficial in ischemia, as it
ill decrease the neuronal depolarization caused by glu-
amate, or thought to be harmful, as it can cause cell
amage by inducing an influx of Cl ions through GABAA
eceptors, followed by water influx and cell swelling (Ingle-
eld and Schwartz-Bloom, 1998; Allen et al., 2004). In
he white matter GABAA receptors on oligodendrocytes,
ome of which are localized in the myelinating processes,
re activated during simulated white matter ischemia
Káradóttir et al., unpublished observations) but the situa-
ion is slightly different, because ECl is positive to the
esting potential (Lin and Bergles, 2004; Kirchhoff and
ettenmann, 1992; and see above). Thus, activating
ABAA receptors will depolarize the cell (perhaps evoking
Ca2 influx through voltage-gated Ca2 channels) but, in
ontrast to the situation in neurons, will let Cl out of the
ell and decrease intracellular osmolarity. This activation
f GABAA receptors during ischemia has been reported to
ecrease action potential conduction in the spinal cord
Lee et al., 1993). Interestingly the anti-epileptic drug vi-
abatrin, which raises extracellular GABA levels by inhib-
ting the GABA degrading enzyme GABA transaminase,
an cause swelling and loss of myelin (Sidhu et al., 1997),
uggesting that excessive activation of GABAA receptors
n the myelinating processes of oligodendrocytes may
amage those processes.
On the other hand, Fern et al. (1995) reported that
ABA release ameliorated action potential conduction loss
n optic nerve ischemia by acting through GABAB recep-
ors. Similarly activation of oligodendrocyte dopamine D2
nd D3 receptors by exogenous agonists has been sug-
ested to reduce oligodendrocyte damage caused by glu-
amate or energy deprivation (Rosin et al., 2005), and
elatonin reduces oxidative damage to white matter after
ctivation of glutamate receptors or ischemia either by
nhibiting adenylate cyclase or through its free radical
cavenging activity (Husson et al., 2002; Lee et al., 2005).
GENOME INSTABILITY AND
NEUROTRANSMITTER SIGNALING TO
OLIGODENDROCYTES
variety of neurological disorders are associated with
utations in neurotransmitter receptors, transporters or
ssociated proteins. For example, in mice, the lurcher
utation in the GluRdelta2 subunit and the weaver muta-
ion in a G protein-gated inwardly rectifying channel cause
ovement disorders by disrupting cerebellar function,
hile the stargazermutation in a protein regulating traffick-
ng of AMPA receptors and calcium channels leads to
bsence seizures and ataxia. In humans, GABAA and
icotinic ACh receptor mutations can cause epilepsy, and
euroticism and depression are associated with a polymor-
hism in the promoter for the 5-HT transporter (Steinlein et
l., 1995; Baulac et al., 2001; Harkins and Fox, 2002;
etts, 2005; Vogel et al., 2006; Munafo et al., 2006). nA large number of genetic disorders are also known to
ffect the white matter. These largely reflect myelination
efects due to mutations causing defects in enzymes such
s arylsulphatase A (metachromatic leukodystrophy), as-
artoacylase (Canavan disease), galactosylceramidase
Krabbe disease) or enzymes breaking down phytanic acid
Refsum’s disease), defects in a fatty acid transfer protein
adrenoleukodystrophy), or defects in the myelin protein
LP1 (Pelizaeus-Merzbacher disease). Although our un-
erstanding of neurotransmitter signaling to oligodendro-
ytes is in its infancy, it is likely that genetic disorders of
his signaling, similar to those in gray matter, will also
ccur, even if in some cases their effects may be masked
y effects of the mutation on gray matter function. In ad-
ition, when mutations occur in oligodendrocytes in mole-
ules not related to neurotransmitter signaling, it is possi-
le that neurotransmitter signaling to the oligodendrocytes
ay modulate the consequences. Here we highlight three
ossible examples.
First, glutamatergic signaling to oligodendrocytes is
xpected to depend on glutamate transporters to maintain
low extracellular glutamate: indeed, blocking these trans-
orters raises the extracellular glutamate concentration
nd damages oligodendrocytes and axons (Domercq et
l., 2005). A common polymorphism in the promoter for the
lutamate transporter EAAT2/GLT1, which is expressed in
hite matter (Domercq and Matute, 1999; Domercq et al.,
999), leads to less transporter expression, a raised ex-
racellular glutamate concentration and worse outcome in
troke (Mallolas et al., 2006). It seems likely that this
olymorphism will also predispose to worse outcome in
hite matter disorders that are caused in part by gluta-
ate, such as spinal cord injury and multiple sclerosis.
Second, some cases of Alzheimer’s disease are
aused by mutations in the presenilin-1 gene (Sherrington
t al., 1995), which generates part of the gamma secretase
omplex that cleaves amyloid precursor protein, releasing
he amyloid  peptide which is deposited in amyloid
laques in this disorder. Interestingly, glutamate-mediated
amage to oligodendrocytes is potentiated by a preseni-
in-1 mutation, possibly as a result of amyloid  impairing
ntracellular calcium regulation so that glutamate evokes a
arger [Ca2]i rise in the cells (Pak et al., 2003).
Finally, neurotransmitter signaling may modulate the
onsequences of mutations causing oligodendrogliomas, a
ignificant class of brain cancer. Glioma malignancy cor-
elates inversely with GABAA receptor expression (Jus-
ofie et al., 1994). Since GABA and glutamate suppress
he proliferation of neurons (LoTurco et al., 1995) and
ossibly oligodendrocytes (see above and Fig. 2), and
ligodendroglioma cells (like oligodendrocytes) express
ABAA and glutamate receptors (Labrakakis et al.,
998a, b), it is possible that GABAergic and glutamatergic
ignaling could inhibit oligodendroglioma growth.
CONCLUSIONS
n comparison with the gray matter, neurotransmitter sig-
aling in the white matter has received relatively little at-
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R. Káradóttir and D. Attwell / Neuroscience 145 (2007) 1426–1438 1435ention, but it is likely to play a major role in both the life and
eath of oligodendrocytes. Novel therapeutic strategies for
reating white matter diseases may be possible based on
he presence in oligodendrocytes of NMDA receptors with
subunit stoichiometry that differs from that of most NMDA
eceptors in neurons.
cknowledgments—Supported by the Wellcome Trust and a
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